Post Profile






Old technology: NHS uses 10% of world's pagers at annual cost of £6.6m

Report into NHS communications says it uses 130,000 pagers and it is surprising ‘legacy equipment is relied upon in emergency situations’ More than one in 10 of the world’s pagers is being used in the NHS, according to estimates. A report looking at communications within the National Health Service said around 130,000 of the devices were employed at an annual cost of £6.
read more

share

Related Posts


These maps show how dangerous illegal drugs flow around the globe

Business & Finance : Business Insider: Money Game

The UN Office on Drugs and Crime released its annual World Drug Report this month, detailing the prevailing trends in global drug cultivation, trafficking, and use. Relying on surveys and other data, the UN estimated that 1 in 20 ad...

The UK's First Hypo Awareness Week - Pinpointing The High Cost Of Treating Low Blood Sugar

Health : Medical News Today

As the first ever national 'Hypo Awareness Week' is staged by NHS Diabetes from Monday 13th to Sunday 19th August, a recent online study in the journal Diabetic Medicine1 has estimated the annual cost of emergency calls for severe h...

Heathrow Airport Saves $310,000, 130 Million Liters of Water Using GE Water Water Treatments

Utilities / Energy : Environmental Management & Energy News

London’s Heathrow Airport has saved more than 130 million liters of water annually using General Electric’s water treatment technologies, GE says, adding that its technologies also saved the UK’s largest airport $310,000 in a year. ...

Breast cancer drug rejected for NHS use on cost-benefit grounds

Health : The Guardian: Health

Charities angered by guidance on Kadcyla, which costs £90,000 per year per patient and gives extra nine months on average A breast cancer drug that costs £90,000 a year per patient has been turned down for use by the NHS on financia...

Breast cancer drug that can extend patients' lives approved for NHS use

Health : The Guardian: Health

Joy as deal struck to make Kadcyla, which costs an annual £90,000 per patient at full price, available for routine use A drug that can extend the lives of women with advanced breast cancer has been approved for routine use on the NH...

Comments


Copyright © 2016 Regator, LLC